GSK and AstraZeneca both aim to hit ambitious revenue targets.

The entities involved

• GSK →

  British multinational pharmaceutical and biotechnology company

  • Uncertainty over a dispute involving GSK and AnaptysBio weighed on market sentiment.Sat 23:22
  • FDA approved a GSK drug and authorized a Roche blood test for eligibility, amidst estimates of 1.7M chronic HBV patients in the US.Fri 12:54
• AstraZeneca →

  British-Swedish pharmaceutical company

  • Dan Janiak joined OncoC4 as Chief Business Officer, having previously served at AstraZeneca.Mon 13:33
  • AstraZeneca presented trial results for its IMFINZI cancer treatment at the European Society for Medical Oncology (ESMO) Congress in Madrid.Mon 01:52

Related events

• Shell overtook HSBC as the most valuable company, while AstraZeneca and Unilever are noted as global peers.Sun 07:22
• AstraZeneca listed shares on the New York Stock Exchange to attract investors.Fri 15:42